Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
CD4 T Cells All Aquiver and Poised for Action One Year After the STEP Vaccine A quick immunology overview HIV (or parts of HIV from a vaccine) are Engulfed by Surveillance Cells HIV, or vaccine components Surveillance Cell HIV (or parts of HIV from a vaccine) are Engulfed by Surveillance Cells HIV (or parts of HIV from a vaccine) are Engulfed by Surveillance Cells Surveillance Cells Cut Up Virus/Vaccine Parts into Different Little Bits Little Bits of Virus (or Vaccine Parts) are Presented on the Surface of the Surveillance Cells EPITOPES (peptides- 15 amino acids long) CD4 T Cells become Excited (all aquiver and poised for action) when Presented with their Epitope CD4 CD4 EPITOPE (peptide) EPITOPE (peptide) CD4 T Cells are the Conductors of the Immune Orchestra CD4 CD4 IL2 cytokine IL4 cytokine IFNg cytokine IL10 cytokine TNFa cytokine (polyfunctional) CD4 T Cells are the Conductors of the Immune Orchestra CD4 CD4 IL2 cytokine IL4 cytokine IFNg cytokine IL10 cytokine TNFa cytokine CD8 Killer CD8 T Cell Killer Antibodies Rationale WHY CD4? CD4 T cells help optimize the killing activity of CD8 T cells CD4 T cells enhance antibody responses WHY STEP? Important to work out what went right with this vaccine regime Need to Know Which Parts of the Vaccine Excited the CD4 T Cells Identifying CD4 Epitopes Using Gag Peptide Pools Gag Master pool Maxipools 1&2 23&24 .............. Minipools 1 1.1, 1.2, 1.3, 1.4, 1.5 2 .............. 23 23.1, 23.2, 23.3, 23.4, 23.5 2.1, 2.2, 2.3, 2.4, 2.5 24 24.1, 24.2, 24.3, 24.4, 24.5, 24.6, 24.7 Single 15mers 1,2,3,4,5,6,7,8,9,10..............111,112,113,114,115,116,117,118,119,120,121,122 overlapping by 11aa Gag gene 1. 2. MGARASVLSGGELDR (epitope peptide) ASVLSGGELDRWEKI (epitope peptide) MGARASVLSGGELDRWEKI ............................................................ LTSLRSLFGNDPSSQ A representative example of identifying the epitope that elicited a Gag-specific CD4 T cell response one year post STEP vaccination (PTID 13837) Gag-specific CD4 DMSO Gag Master Pool epitope mapping Pool Positive? Gag Master Maxipool 1&2 Gag Maxipool 1&2 Gag Maxipool 9&10 Gag Maxipool 21&22 Gag Maxipool 23&24 5&6 7&8 IFN-g 3&4 9&10 11&12 13&14 15&16 17&18 19&20 21&22 23&24 IL-2 To Investigate Gag Maxipool 21 & 22 Overlapping 15mer Peptides We need to test the participant’s CD4 cells with the 10, single 15mer peptides that make up this Maxipool 21.1 21.2 21.3 21.4 21.5 22.1 22.2 22.3 22.4 22.5 Positive? To Investigate Gag Maxipool 21 & 22 Gag single 15mer peptide, 22.2, elicits no more CD4 response than the DMSO negative control, therefore is negative. IFN-g DMSO Gag single 15mer 22.2 IL-2 TNF-a To Investigate Gag Maxipool 21 & 22 Gag single 15mer peptide, 22.3, elicits a higher, CD4 response than the DMSO negative control, therefore is positive. IFN-g DMSO Gag single 15mer 22.3 IL-2 TNF-a To Investigate Gag Maxipool 21 & 22 DMSO Gag single 15mer 22.4 IFN-g Gag single 15mer peptide, 22.4, elicits a higher, CD4 response than the DMSO negative control, therefore is positive. IL-2 TNF-a To Investigate Gag Maxipool 21 & 22 Gag single 15mer peptide, 22.5, elicits no more CD4 response than the DMSO negative control, therefore is negative. IFN-g DMSO Gag single 15mer 22.5 IL-2 TNF-a To Investigate Gag Maxipool 21 & 22 Overlapping 15mer Peptides 21.1 21.2 21.3 21.4 21.5 22.1 22.2 22.3 22.4 22.5 Positive? PTID 13837’s CD4 T Cell Gag Epitope Gag 15mer peptide 22.4 Gag 15mer peptide 22.3 R429QANFLGKIWPSHKGRPGN447 Gag gene Relative Positions of Gag CD4 Epitopes (481) (477) (293) (41) (297) (73) (261) (37) Gag gene (297) (477) (465) (385) (373) (429) (465) Cytokine Profile of Epitope-Specific CD4 T Cells One Year Post Vaccination Vaccinated PTID 9952 This participant had a vaccine-induced CD4 T cell response to Gag epitope 24.5 and 24.6 (from maxipool 23 & 24). This participant then became infected with HIV. Will this vaccine-induced response still be dominant after infection? ag G 9& 8 7& 6 5& 4 3& 2 1& er as t Stimulant 24 .7 24 .6 24 .5 24 .4 24 .3 24 .2 24 .1 10 11 & 12 13 & 14 15 & 16 17 & 18 19 & 20 21 & 22 23 & 24 M Antigen Specific CD4 T Cell Response (%) Infected, vaccinated PTID 9952 one year post vaccination 9952 CD4 Gag Responses IFNg & IL2 & TNFa 0.20 0.15 0.10 0.05 0.00 ag G 9& 8 7& 6 5& 4 3& 2 1& er as t Stimulant 24 .7 24 .6 24 .5 24 .4 24 .3 24 .2 24 .1 10 11 & 12 13 & 14 15 & 16 17 & 18 19 & 20 21 & 22 23 & 24 M Antigen Specific CD4 T Cell Response (%) Infected, vaccinated PTID 9952 one year post vaccination 9952 CD4 Gag Responses IFNg & IL2 & TNFa 0.20 0.15 0.10 0.05 0.00 Conclusion Low, vaccine-induced Gag-specific CD4 T cell responses were identified, at one year post vaccination, in uninfected participants in the STEP vaccine trial Two responses in some participants Epitopes located along entire length of Gag gene Most common Gag-specific CD4 T cell response at one year post vaccination was the release of two cytokines, IL2 and TNFa – degree of polyfunctionality. Some vaccine-induced CD4 responses dominate after infection Overall, data suggests utility of these vaccine-induced, CD4 T cell responses. Acknowledgements Trial participants and the CAB Repository technicians SAL Endpoints Evan Thomas and Janice Chen Nicole Frahm Steve de Rosa Julie McElrath National Health & Medical Research Council (NHMRC), Australia